OSL logo.png
OncoSil Medical Ltd
(ASX:OSL)

Overview

Oncosil Medical (ASX:OSL) is a Sydney based  medical device company focused on Interventional Oncology in the pancreas and liver.

Our Latest Articles on OncoSil Medical Ltd


Type Date Title
Article 05-May-2020 OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe
Article 30-Jan-2020 ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients

Market Data


Latest Article

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.

Related Articles

ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients

ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients

OncoSil Medical (ASX: OSL) has developed a first-in-class, truly innovative device that treats unresectable locally advanced pancreatic cancer — that is, tumours that can’t be surgically removed.

Thanks for subscribing!

X